Drug Type Immune stimulating antibody conjugate (ISAC) |
Synonyms- |
Target |
Mechanism CLDN18.2 modulators(Claudin 18.2 modulators), TLR7 modulators(Toll like receptor 7 modulators), TLR8 modulators(Toll like receptor 8 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stomach Cancer | Preclinical | CN | 01 Nov 2023 | |
Stomach Cancer | Preclinical | US | 01 Nov 2023 |